Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Construction of oncolytic herpes simplex viruses (oHSV) obligate vector and constructs for cancer therapy

US Patent 11439679 · Granted Sep 13, 2022

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →